Literature DB >> 29170089

Schistosomiasis in the first 1000 days.

Joseph B Freer1, Claire D Bourke2, Gunn H Durhuus3, Eyrun F Kjetland4, Andrew J Prendergast5.   

Abstract

Infections during the first 1000 days-the period from conception to a child's second birthday-can have lifelong effects on health, because this is a crucial phase of growth and development. There is increasing recognition of the burden and potential effects of schistosomiasis in women of reproductive age and young children. Exposure to schistosomes during pregnancy can modulate infant immune development and schistosomiasis can occur from early infancy, such that the high disease burden found in adolescents is often due to accumulation of infections with long-lived schistosomes from early life. Women of reproductive age and young children are largely neglected in mass drug administration programmes, but early treatment could avert subsequent disease. We evaluate the evidence that early schistosomiasis has adverse effects on birth, growth, and development. We also discuss the case for expanding public health interventions for schistosomiasis in women of reproductive age and preschool-age children, and the need for further research to evaluate the potential of treating women pre-conception to maximise health across the life course.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29170089     DOI: 10.1016/S1473-3099(17)30490-5

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  13 in total

1.  Screening Program for Imported Diseases in Immigrant Women: Analysis and Implications from a Gender-Oriented Perspective.

Authors:  José A Boga; Luis Casado; Jonathan Fernández-Suarez; Noelia Moran; Mercedes Rodríguez-Perez; María Martínez-Sela; Ana Pérez; Alicia Garcia-Perez; Candela Menendez; Sagrario Santos; Azucena Rodriguez-Guardado
Journal:  Am J Trop Med Hyg       Date:  2020-04-23       Impact factor: 2.345

2.  Host-Specific Serum Factors Control the Development and Survival of Schistosoma mansoni.

Authors:  Sören Frahm; Ulrich Fabien Prodjinotho; Sonakshi Bhattacharjee; Admar Verschoor; Clarissa Prazeres da Costa
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

3.  Schistosoma mansoni immunomodulatory molecule Sm16/SPO-1/SmSLP is a member of the trematode-specific helminth defence molecules (HDMs).

Authors:  Jenna Shiels; Krystyna Cwiklinski; Raquel Alvarado; Karine Thivierge; Sophie Cotton; Bibiana Gonzales Santana; Joyce To; Sheila Donnelly; Clifford C Taggart; Sinead Weldon; John P Dalton
Journal:  PLoS Negl Trop Dis       Date:  2020-07-09

4.  Schistosoma haematobium infection is associated with alterations in energy and purine-related metabolism in preschool-aged children.

Authors:  Derick N M Osakunor; Takafira Mduluza; Douglas Osei-Hyiaman; Karl Burgess; Mark E J Woolhouse; Francisca Mutapi
Journal:  PLoS Negl Trop Dis       Date:  2020-12-14

5.  Effect of maternal praziquantel treatment for Schistosoma japonicum infection on the offspring susceptibility and immunologic response to infection at age six, a cohort study.

Authors:  Susannah Colt; Blanca Jarilla; Palmera Baltazar; Veronica Tallo; Luz P Acosta; Hannah W Wu; Christopher V Barry; Jonathan D Kurtis; Remigio M Olveda; Jennifer F Friedman; Mario A Jiz
Journal:  PLoS Negl Trop Dis       Date:  2021-04-16

Review 6.  Schistosomes in the Lung: Immunobiology and Opportunity.

Authors:  Emma L Houlder; Alice H Costain; Peter C Cook; Andrew S MacDonald
Journal:  Front Immunol       Date:  2021-04-19       Impact factor: 7.561

Review 7.  Schistosomiasis Control: Leave No Age Group Behind.

Authors:  Christina L Faust; Derick N M Osakunor; Jennifer A Downs; Sekeleghe Kayuni; J Russell Stothard; Poppy H L Lamberton; Jutta Reinhard-Rupp; David Rollinson
Journal:  Trends Parasitol       Date:  2020-05-16

8.  Urogenital schistosomiasis infection prevalence targets to determine elimination as a public health problem based on microhematuria prevalence in school-age children.

Authors:  Ryan E Wiegand; Fiona M Fleming; Anne Straily; Susan P Montgomery; Sake J de Vlas; Jürg Utzinger; Penelope Vounatsou; W Evan Secor
Journal:  PLoS Negl Trop Dis       Date:  2021-06-11

9.  Higher frequency of circulating Vδ1 γδT cells in patients with advanced schistosomiasis.

Authors:  Li Zheng; Lixia Wang; Yuan Hu; Jia Yi; Lun Wan; Yujuan Shen; Si Liu; Xiaorong Zhou; Jianping Cao
Journal:  Parasite Immunol       Date:  2021-07-21       Impact factor: 2.206

10.  Fine-scale heterogeneity in Schistosoma mansoni force of infection measured through antibody response.

Authors:  Benjamin F Arnold; Henry Kanyi; Sammy M Njenga; Fredrick O Rawago; Jeffrey W Priest; W Evan Secor; Patrick J Lammie; Kimberly Y Won; Maurice R Odiere
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.